CXCR3 and Alzheimer disease: In AD postmortem brain tissue, CXCL10 was increased in reactive astrocytes, while CXCR3 was constitutively expressed in a subpopulation of neurons, suggesting that CXCL10 binding could lead to neuronal dysfunction and apoptosis [20, 65, 94, 104].